In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye

被引:10
作者
Babiole, M [1 ]
Wilhelm, F [1 ]
Schoch, C [1 ]
机构
[1] Novartis Ophthalm AG, Ophtha Tech Dev, CH-4002 Basel, Switzerland
关键词
D O I
10.1089/10807680151125492
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The corneal permeability, hydrolysis, and metabolism of unoprostone isopropyl (UI), a docosanoid, were examined in isolated porcine ocular tissues. The apparent permeability coefficient (Papp) of the esterified prodrug and of the acid metabolite were determined in a modified Valia-Chien permeation chamber and quantified by high performance liquid chromatography. Enzymatic hydrolysis and subsequent metabolism were examined in isolated tissue homogenates. The prodrug (ester form) was found to permeate the isolated intact porcine cornea with a Papp of 9.97 x 10(-7) cm/sec. Only the acid metabolite could be detected in the receiver chamber, indicating the requirement of hydrolysis for permeation. The acid metabolite could not permeate the intact cornea but was able to cross an epithelium-denuded cornea with a Papp of 1.22 X 10(-6) cm/sec. Enzymatic hydrolysis of UI was confined to the isolated intact cornea and epithelium, indicating that the esterase activity was localized ill the corneal epithelium. Incubations with different porcine ocular tissues, conjunctiva, iris-ciliary body, trabeculum, as well as aqueous humor, did not reveal other metabolites. These findings demonstrate that the ocular penetration of UI is dependent on its uptake into the epithelium and subsequent hydrolysis prior to its penetration into the anterior chamber, a very common pathway for ophthalmic drugs. In the pig eye, unoprostone does not appear to be further metabolized.
引用
收藏
页码:159 / 172
页数:14
相关论文
共 26 条
[1]   PHYSICOCHEMICAL DETERMINANTS OF DRUG DIFFUSION ACROSS THE CONJUNCTIVA, SCLERA, AND CORNEA [J].
AHMED, I ;
GOKHALE, RD ;
SHAH, MV ;
PATTON, TF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (08) :583-586
[2]   CORNEAL PERMEABILITY TO AND OCULAR METABOLISM OF PHENYL-SUBSTITUTED PROSTAGLANDIN ESTERS IN-VITRO [J].
BASU, S ;
SJOQUIST, B ;
STJERNSCHANTZ, J ;
RESUL, B .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1994, 50 (04) :161-168
[4]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[5]   PERMEABILITY OF PROSTAGLANDIN-F2-ALPHA AND PROSTAGLANDIN-F2-ALPHA ESTERS ACROSS CORNEA INVITRO [J].
CAMBER, O ;
EDMAN, P ;
OLSSON, LI .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 29 (2-3) :259-266
[6]   FACTORS INFLUENCING THE CORNEAL PERMEABILITY OF PROSTAGLANDIN-F2-ALPHA AND ITS ISOPROPYL ESTER INVITRO [J].
CAMBER, O ;
EDMAN, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 37 (1-2) :27-32
[7]  
CHERUKURY M, 1998, J OCUL PHARMACOL TH, V14, P389
[8]   DEVELOPMENT OF A DYNAMIC SKIN PERMEATION SYSTEM FOR LONG-TERM PERMEATION STUDIES [J].
CHIEN, YW ;
VALIA, KH .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1984, 10 (04) :575-599
[9]  
EDELHAUSER HF, 1988, ARCH OPHTHALMOL-CHIC, V106, P1110
[10]  
HIGAKI K, 1995, DRUG METAB DISPOS, V23, P35